Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul>
<li>Organto reported Q3 financials that were weaker than expected due to weather and regulatory issues.</li>
<li>Yesterday after market close, Organto Foods (OGO:TSXV) reported Q3 financial results that came in weaker than expected but guided for a stronger 2024.</li>
<li>Gross margin for the quarter came in at 8.6% compared to our estimate of 8.5% and 3.7% last year.</li>
</ul>


Organto reported Q3 financials that were weaker than expected due to weather and regulatory issues.
Yesterday after market close, Organto Foods (OGO:TSXV) reported Q3 financial results that came in weaker than expected but guided for a stronger 2024.
Gross margin for the quarter came in at 8.6% compared to our estimate of 8.5% and 3.7% last year.


OGO: Q3 Financials Miss but 2024 Outlook Improves